Members |
acceptabilityId |
2 bulky (UICC) |
Acceptable (foundation metadata concept) |
2 dimethylaminoethanol |
Acceptable (foundation metadata concept) |
2 female babies |
Acceptable (foundation metadata concept) |
2 fingers |
Preferred (foundation metadata concept) |
2 fingers (qualifier value) |
Preferred (foundation metadata concept) |
2 hour post-prandial blood glucose level |
Preferred (foundation metadata concept) |
2 hour post-prandial blood glucose level |
Preferred (foundation metadata concept) |
2 hour post-prandial blood glucose level (procedure) |
Preferred (foundation metadata concept) |
2 hour post-prandial blood glucose level (procedure) |
Preferred (foundation metadata concept) |
2 hour urine specimen |
Preferred (foundation metadata concept) |
2 hour urine specimen (specimen) |
Preferred (foundation metadata concept) |
2 hourly |
Acceptable (foundation metadata concept) |
2 hours |
Preferred (foundation metadata concept) |
2 hours (qualifier value) |
Preferred (foundation metadata concept) |
2 hours post food blood sugar |
Acceptable (foundation metadata concept) |
2 hours post food blood sugar |
Acceptable (foundation metadata concept) |
2 hours post-dose |
Preferred (foundation metadata concept) |
2 hours post-dose (qualifier value) |
Preferred (foundation metadata concept) |
2 hours post-food blood sugar |
Acceptable (foundation metadata concept) |
2 hours post-food blood sugar level |
Acceptable (foundation metadata concept) |
2 inch |
Preferred (foundation metadata concept) |
2 inch (qualifier value) |
Preferred (foundation metadata concept) |
2 level of presenting part in relation to ischial spines |
Preferred (foundation metadata concept) |
2 level of presenting part in relation to ischial spines (finding) |
Preferred (foundation metadata concept) |
2 male + 1 female babies |
Acceptable (foundation metadata concept) |
2 male babies |
Acceptable (foundation metadata concept) |
2 o'clock position |
Preferred (foundation metadata concept) |
2 o'clock position (qualifier value) |
Preferred (foundation metadata concept) |
2 o'clock position on mammogram |
Preferred (foundation metadata concept) |
2 o'clock position on mammogram (finding) |
Preferred (foundation metadata concept) |
2 part fracture |
Preferred (foundation metadata concept) |
2 part fracture (morphologic abnormality) |
Preferred (foundation metadata concept) |
2 point kneeling |
Acceptable (foundation metadata concept) |
2 serotype |
Preferred (foundation metadata concept) |
2 serotype (qualifier value) |
Preferred (foundation metadata concept) |
2 serotypes |
Acceptable (foundation metadata concept) |
2 times a day Monday, Wednesday and Friday |
Acceptable (foundation metadata concept) |
2 to 4 seizures a month |
Preferred (foundation metadata concept) |
2 to 4 seizures a month (finding) |
Preferred (foundation metadata concept) |
2 to 4 times a day |
Acceptable (foundation metadata concept) |
2 toed sloth |
Acceptable (foundation metadata concept) |
2'(3')-polynucleotidase |
Acceptable (foundation metadata concept) |
2',3'-cyclic-nucleotide 2'-phosphodiesterase |
Preferred (foundation metadata concept) |
2',3'-cyclic-nucleotide 2'-phosphodiesterase (substance) |
Preferred (foundation metadata concept) |
2',3'-cyclic-nucleotide 3'-phosphodiesterase |
Preferred (foundation metadata concept) |
2',3'-cyclic-nucleotide 3'-phosphodiesterase (substance) |
Preferred (foundation metadata concept) |
2'-5'-oligoadenylate synthetase 1-related infantile-onset pulmonary alveolar proteinosis, hypogammaglobulinaemia |
Acceptable (foundation metadata concept) |
2'-carboxybenzalpyruvate aldolase |
Acceptable (foundation metadata concept) |
2'-deoxyadenosine |
Acceptable (foundation metadata concept) |
2'-deoxyguanosine |
Acceptable (foundation metadata concept) |
2'-deoxyinosine |
Acceptable (foundation metadata concept) |
2'-hydroxydaidzein reductase |
Preferred (foundation metadata concept) |
2'-hydroxydaidzein reductase (substance) |
Preferred (foundation metadata concept) |
2'-hydroxyisoflavone reductase |
Preferred (foundation metadata concept) |
2'-hydroxyisoflavone reductase (substance) |
Preferred (foundation metadata concept) |
2+ pitting edema (finding) |
Preferred (foundation metadata concept) |
2+ pitting oedema |
Preferred (foundation metadata concept) |
2, 3 Diphosphoglycerate |
Preferred (foundation metadata concept) |
2, 3 Diphosphoglycerate (substance) |
Preferred (foundation metadata concept) |
2,2,2-trichloroethanol |
Acceptable (foundation metadata concept) |
2,2,2-trifluoroethanol |
Preferred (foundation metadata concept) |
2,2,2-trifluoroethanol (substance) |
Preferred (foundation metadata concept) |
2,2,3,3,4,4,4-heptafluorobutan-1-ol |
Preferred (foundation metadata concept) |
2,2,3,3,4,4,4-heptafluorobutan-1-ol (substance) |
Preferred (foundation metadata concept) |
2,2,4-trimethyl-1,2-dihydroquinoline |
Preferred (foundation metadata concept) |
2,2,4-trimethyl-1,2-dihydroquinoline (substance) |
Preferred (foundation metadata concept) |
2,2,4-trimethyl-1,2-dihydroquinoline only product |
Preferred (foundation metadata concept) |
2,2,4-trimethyl-1,2-dihydroquinoline-containing product |
Preferred (foundation metadata concept) |
2,2,4-trimethylpentane |
Preferred (foundation metadata concept) |
2,2,4-trimethylpentane (substance) |
Preferred (foundation metadata concept) |
2,2-Dichloro-1,1-difluoroethylmethyl ether |
Preferred (foundation metadata concept) |
2,2-Dichloro-1,1-difluoroethylmethyl ether (substance) |
Preferred (foundation metadata concept) |
2,2-di(4-methacryloxyphenyl)propane |
Preferred (foundation metadata concept) |
2,2-di(4-methacryloxyphenyl)propane (substance) |
Preferred (foundation metadata concept) |
2,2-dialkylglycine decarboxylase (pyruvate) |
Preferred (foundation metadata concept) |
2,2-dialkylglycine decarboxylase (pyruvate) (substance) |
Preferred (foundation metadata concept) |
2,2-dichloro-1,1-difluoroethyl methyl ether |
Acceptable (foundation metadata concept) |
2,2-dichloropropanoic acid |
Acceptable (foundation metadata concept) |
2,2-dichlorovinyl dimethyl phosphate |
Acceptable (foundation metadata concept) |
2,2-dimethyl-3-(3-methylphenyl)propanol |
Acceptable (foundation metadata concept) |
2,2-dimethylpropane |
Preferred (foundation metadata concept) |
2,2-dimethylpropane (substance) |
Preferred (foundation metadata concept) |
2,3 - dihydroxypropanoic acid |
Acceptable (foundation metadata concept) |
2,3 DPG - 2,3-diphosphoglycerate |
Acceptable (foundation metadata concept) |
2,3 epoxy-1-propanol |
Acceptable (foundation metadata concept) |
2,3,4,5-tetrahydropyridine-2-carboxylate N-succinyltransferase |
Preferred (foundation metadata concept) |
2,3,4,5-tetrahydropyridine-2-carboxylate N-succinyltransferase (substance) |
Preferred (foundation metadata concept) |
2,3,5-Trichlorophenoxyacetic acid |
Preferred (foundation metadata concept) |
2,3-Diaminopropionate oxalyltransferase |
Preferred (foundation metadata concept) |
2,3-Diaminopropionate oxalyltransferase (substance) |
Preferred (foundation metadata concept) |
2,3-diaminopropionate N-oxalyltransferase |
Preferred (foundation metadata concept) |
2,3-diaminopropionate N-oxalyltransferase (substance) |
Preferred (foundation metadata concept) |
2,3-dihydro-2,3-dihydroxybenzoate dehydrogenase |
Preferred (foundation metadata concept) |
2,3-dihydro-2,3-dihydroxybenzoate dehydrogenase (substance) |
Preferred (foundation metadata concept) |
2,3-dihydro-2,3-dihydroxybenzoate synthase |
Acceptable (foundation metadata concept) |
2,3-dihydroxybenzoate 2,3-dioxygenase |
Preferred (foundation metadata concept) |
2,3-dihydroxybenzoate 2,3-dioxygenase (substance) |
Preferred (foundation metadata concept) |
2,3-dihydroxybenzoate 3,4-dioxygenase |
Preferred (foundation metadata concept) |
2,3-dihydroxybenzoate 3,4-dioxygenase (substance) |
Preferred (foundation metadata concept) |
2,3-dihydroxybenzoate serine ligase |
Preferred (foundation metadata concept) |
2,3-dihydroxybenzoate serine ligase (substance) |
Preferred (foundation metadata concept) |